Cohort study examines therapeutic effects of glucagon-like peptide-1 receptor agonists in hidradenitis suppurativa patients, indicating potential for improved treatment outcomes.
This cohort study investigates the potential therapeutic benefits of glucagon-like peptide-1 receptor agonists in patients with hidradenitis suppurativa.
No takes yet. Share an insight, caveat, or question.
Gouvrion et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: